Mission Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.54M Sell
5,709
-1,202
-17% -$535K 0.05% 180
2025
Q1
$3.35M Buy
6,911
+859
+14% +$416K 0.08% 132
2024
Q4
$2.44M Sell
6,052
-575
-9% -$232K 0.06% 156
2024
Q3
$3.08M Buy
6,627
+815
+14% +$379K 0.07% 132
2024
Q2
$2.72M Sell
5,812
-1,995
-26% -$935K 0.07% 137
2024
Q1
$3.26M Buy
7,807
+2,914
+60% +$1.22M 0.09% 125
2023
Q4
$1.99M Buy
4,893
+212
+5% +$86.3K 0.06% 144
2023
Q3
$1.63M Buy
4,681
+70
+2% +$24.3K 0.06% 149
2023
Q2
$1.62M Buy
4,611
+21
+0.5% +$7.39K 0.06% 148
2023
Q1
$1.45M Buy
4,590
+64
+1% +$20.2K 0.06% 162
2022
Q4
$1.31M Buy
4,526
+164
+4% +$47.4K 0.06% 159
2022
Q3
$1.26M Buy
4,362
+96
+2% +$27.8K 0.07% 146
2022
Q2
$1.2M Buy
4,266
+658
+18% +$185K 0.06% 160
2022
Q1
$942K Buy
3,608
+492
+16% +$128K 0.04% 199
2021
Q4
$684K Sell
3,116
-55
-2% -$12.1K 0.03% 237
2021
Q3
$575K Buy
3,171
+57
+2% +$10.3K 0.03% 246
2021
Q2
$628K Buy
3,114
+63
+2% +$12.7K 0.03% 245
2021
Q1
$656K Buy
3,051
+490
+19% +$105K 0.04% 210
2020
Q4
$605K Buy
2,561
+332
+15% +$78.4K 0.04% 195
2020
Q3
$607K Buy
2,229
+44
+2% +$12K 0.05% 170
2020
Q2
$634K Buy
2,185
+52
+2% +$15.1K 0.05% 159
2020
Q1
$508K Sell
2,133
-7
-0.3% -$1.67K 0.06% 160
2019
Q4
$469K Buy
2,140
+125
+6% +$27.4K 0.05% 189
2019
Q3
$341K Sell
2,015
-459
-19% -$77.7K 0.04% 212
2019
Q2
$454K Sell
2,474
-264
-10% -$48.4K 0.05% 181
2019
Q1
$504K Buy
2,738
+231
+9% +$42.5K 0.06% 168
2018
Q4
$415K Buy
2,507
+465
+23% +$77K 0.05% 167
2018
Q3
$394K Hold
2,042
0.05% 176
2018
Q2
$347K Buy
+2,042
New +$347K 0.05% 177